The window for organ donation after death is surprisingly short and depends on which organ is involved. Hearts and lungs tolerate only about four to six hours outside the body under standard cold storage, while kidneys can last roughly 24 to 36 hours. Livers fall somewhere in between. But these numbers are not fixed limits carved in stone; they shift depending on how death is determined, how the organ is preserved, and how far it needs to travel. Newer preservation technologies are pushing those boundaries further than many transplant professionals thought possible even a decade ago.
Why the Clock Starts Before You Think
The moment blood stops flowing to an organ, cells begin running out of energy. Without oxygen, tissues switch to less efficient metabolic pathways, waste products accumulate, and cellular structures start to break down. This process, called ischemia, is the central enemy of organ transplantation. Every minute an organ spends without adequate blood flow chips away at its viability. The damage from warm ischemia (when an organ sits at body temperature without circulation) is far more destructive than cold ischemia (when the organ has been flushed with cold preservation fluid and placed on ice). That distinction drives nearly every decision in the donation timeline.
For donation after brain death, the traditional and still most common pathway, the donor’s heart continues beating while organs are recovered. This means warm ischemia is minimal. The clock effectively starts when the surgical team clamps the blood vessels and flushes the organs with cold preservation solution. For donation after circulatory death, things are tighter. The heart has already stopped, so organs endure a period of warm ischemia before the team can begin recovery. That agonal phase, the time between withdrawal of life support and actual circulatory arrest, can vary widely. One study of potential donors found that the median time from treatment withdrawal to death was 36 minutes, but the range stretched from 5 minutes to more than 3 days, with over 40% of potential donors still alive one hour after withdrawal.
The Mandatory Waiting Period After Circulatory Death
Once the heart stops in a circulatory-death scenario, surgeons cannot immediately begin recovering organs. A mandatory observation period, often called the “no-touch” interval, must pass to confirm that the heart will not restart on its own. This period exists to ensure the donor is truly dead before organ recovery begins, but it also adds precious minutes of warm ischemia.
How long that waiting period lasts depends on where you are. In much of Europe, the Maastricht Protocol established a 10-minute wait. In the United States, Canada, the United Kingdom, and Spain, protocols initially settled on 5 minutes, and some controlled-donation protocols in the U.S. now use intervals as short as 2 minutes. Italy, by contrast, historically required a 20-minute observation of flat electrical heart activity. These differences reflect genuine ethical and medical disagreements about how long one must observe to be certain the heart will not spontaneously resume beating.
The variation matters for organ quality. Each additional minute of warm ischemia during the no-touch period increases the damage to oxygen-starved tissues. One case report documented successful recovery of cardiac function after a 20-minute no-touch period in a circulatory-death donor, using a technique called normothermic regional perfusion to restore blood flow to the organs while keeping them in the body. That case pushed the boundaries of what was considered possible, but it required a specialized protocol involving preconditioning of the donor and immediate reperfusion after the observation window ended.
Organ-by-Organ Time Limits
Each organ has its own tolerance for ischemia, and these tolerances set the practical limits on how long after death donation can occur.
Hearts
The heart is the most time-sensitive organ. Under standard cold storage, transplant teams generally aim to keep total ischemic time under four hours, and outcomes deteriorate as that window extends. A large registry study found that the impact of ischemic time on survival varies with donor age: when the donor is over about 40 years old, longer ischemic times significantly worsen outcomes. For recipients aged 60 or older, an ischemic time of four hours or more was associated with roughly double the risk of death compared to hearts transplanted within two hours. Younger recipients tolerated longer ischemic times with much smaller penalties.
Donation after circulatory death has historically excluded the heart entirely, since by definition the heart has already stopped. But that is changing. DCD heart transplantation is now performed at a growing number of centers, using techniques to restart and assess the heart after circulatory death. The approach differs fundamentally from brain-death donation in how the organ is recovered, stored, and evaluated.
Lungs
Lungs can generally tolerate about six to eight hours of cold ischemia, though the quality of the organ declines as time increases. Research has shown that the potential for reconditioning lungs with cold ischemic times exceeding eight hours is significantly diminished compared to lungs with shorter preservation times, due to severe injury when blood flow is restored. The biological mechanisms of damage also differ depending on whether the ischemia was warm or cold: the energy reserves and inflammatory profiles of donor lungs look different depending on the type of ischemia they experienced, which has implications for how transplant teams might treat the injury.
Livers
Livers have traditionally been preserved using simple cold storage, with most transplant centers aiming to keep cold ischemic time under about 12 hours. When cold ischemic time increases, so does the risk of the graft not working properly after transplant. A study analyzing long-distance liver transport found that even when livers traveled up to 3,500 kilometers, with cold ischemic times reaching 10 hours or more, the differences in outcomes such as early graft dysfunction and graft loss did not reach statistical significance, though there were worrying trends. Where the liver really distinguishes itself from other organs is in how dramatically machine perfusion technology is changing the rules. A meta-analysis found that livers selected for transplant after machine perfusion tended to have shorter cold ischemic times, but emerging evidence suggests the traditional cold ischemia limits may matter less when normothermic machine perfusion is used. One study found that prolonged cold ischemic time did not adversely affect major outcomes including early graft dysfunction, biliary complications, or hospital stay in a program that routinely used normothermic machine perfusion.
Perhaps more striking, research on machine preservation at body temperature found no adverse outcomes even when the preservation duration exceeded what had previously been considered safe, with the authors concluding that the upper limit is likely beyond 24 hours and has not yet been defined.
Kidneys
Kidneys are the most forgiving of the solid organs. They can be preserved on ice for roughly 24 to 36 hours, though outcomes are better with shorter times. Cold ischemia beyond 12 hours increases the risk of delayed graft function, where the transplanted kidney does not immediately work and the recipient needs temporary dialysis. One study found that kidneys preserved for 12 to 18 hours had roughly double the odds of delayed function compared to those preserved for shorter periods, and kidneys exceeding 18 hours had more than triple the odds. A paired-kidney analysis looking at more than 25,000 kidney pairs confirmed that the kidney with the longer cold ischemic time was more likely to experience delayed graft function. The reassuring finding is that this delay, while inconvenient and stressful, does not appear to significantly affect graft survival or rejection rates during the first year.
The greater distances that kidneys travel compared to hearts or lungs confirm their resilience. A study examining transplant outcomes by travel distance found no significant association between how far a kidney traveled and long-term graft survival, supporting the argument that national sharing systems could improve access without compromising results.
Tissues Have a Much Longer Window
The conversation so far has focused on solid organs, which require blood flow and are metabolically demanding. Tissues like corneas, bone, skin, heart valves, and tendons are a different story entirely. Because these structures have lower metabolic rates and can be processed and stored differently, the recovery window extends far beyond what organs allow. Corneas can generally be recovered up to about 12 to 24 hours after death, and certain musculoskeletal tissues can be recovered within 24 hours or in some cases even longer if the body has been refrigerated. This is why someone who dies in circumstances that make organ donation impossible, such as a prolonged time before discovery, may still be able to donate tissues.
How Preservation Technology Is Rewriting the Rules
For decades, the standard approach was static cold storage: flush the organ with a chilled preservation solution, pack it in ice, and rush it to the recipient. The preservation solutions themselves have evolved considerably. Modern formulations include compounds designed to prevent cells from swelling, scavenge damaging free radicals, and provide energy substrates that cells can use during the cold storage period. Newer solutions incorporate amino acids and antioxidants aimed specifically at reducing the injury caused by cold itself.
The real revolution, though, is machine perfusion. Instead of letting an organ sit passively on ice, machine perfusion continuously pumps fluid through the organ’s blood vessels. This can be done at cold temperatures (hypothermic machine perfusion) or at body temperature (normothermic machine perfusion), and each approach has different strengths. Hypothermic perfusion keeps the organ’s metabolism slow while gently washing away waste products. Normothermic perfusion keeps the organ functioning as if it were still in the body, which allows transplant teams to actually assess whether it works before committing to surgery.
Viability assessment during machine perfusion is a rapidly developing field. For livers on normothermic perfusion, clinicians monitor bile production, acid-base balance, enzyme levels in the fluid, and the composition of bile itself to determine whether the liver is healthy enough to transplant. The differences between fluid and bile levels of pH, bicarbonate, and glucose serve as predictors of whether the bile ducts will develop long-term complications. For kidneys, biomarkers of tubular injury and inflammation in the perfusion fluid can flag organs that are in worse shape, with markers like NAG and IL-6 correlating with visible damage early in the perfusion process.
These assessment tools are what make longer preservation times feasible. When you can continuously monitor an organ’s function, you are no longer guessing about viability based solely on how many hours have passed. You have real-time data.
Supercooling and Other Experimental Frontiers
Researchers are pushing preservation even further with supercooling, a technique that chills organs below the freezing point without allowing ice crystals to form. Ice formation inside cells is catastrophic, rupturing membranes and destroying tissue. But if you can keep an organ liquid at sub-zero temperatures, the metabolic rate drops even lower than standard cold storage allows. A team demonstrated that human livers could be stored at minus 4 degrees Celsius using supercooling followed by machine perfusion at slightly below body temperature, effectively extending the organ’s viable life outside the body by 27 hours compared to conventional storage. If this technology matures and scales, it could fundamentally change transplant logistics by giving surgical teams a much larger geographic radius for matching donors to recipients.
Getting the Organ From Donor to Recipient
Time limits for organs are not just biological. They are logistical. A liver with a theoretical 12-hour preservation window does not actually give the transplant team 12 hours of working time. The total cold ischemic time includes the donor surgery (removing the organ), transport, and the recipient surgery (implanting the organ). Transport alone can consume a substantial fraction of the window. In one series analyzing long-distance liver procurement, transportation time ranged from 1 to 8 hours and accounted for a median of 41% of total cold ischemia time.
Most organ transport relies on a combination of ground vehicles, charter flights, and commercial aviation. Charter flights offer flexibility but are expensive and carry a significant environmental footprint. As allocation policies have expanded to cover larger geographic areas in the name of fairness, transportation distances and costs have increased. Advances in controlled hypothermic preservation have extended safe preservation times enough that some centers are exploring commercial air travel or even ground transport as alternatives to charter flights for longer distances. For kidneys specifically, the evidence suggests that travel distance itself does not meaningfully affect long-term graft survival, lending support to broader sharing policies.
When Donor and Organ Characteristics Collide
The acceptable ischemic time is not the same for every donor. An organ from a young, healthy donor tolerates ischemia better than one from an older donor or one with pre-existing conditions. This interaction between donor characteristics and preservation time creates compound risk. One study analyzing liver transplant outcomes found that a composite score adding donor age and cold ischemic time identified a threshold associated with more than a fivefold increase in early mortality. A similar pattern emerged in heart transplantation, where the influence of ischemic time on survival became apparent at a donor age of roughly 40, with the penalties growing steeper for older donors.
This is why transplant teams do not apply a single universal time limit. A heart from a 25-year-old donor with four hours of ischemic time may be perfectly acceptable, while the same four hours for a heart from a 55-year-old donor could represent unacceptable risk for an older recipient. Every organ offer involves a rapid calculation weighing donor quality, preservation time, recipient urgency, and the logistics of getting everything to the operating room in time.
Normothermic Regional Perfusion and Its Controversies
One of the most significant recent developments in circulatory-death donation is normothermic regional perfusion, or NRP. After the no-touch period has passed and death has been declared, surgeons can restore warm, oxygenated blood flow to the abdominal or thoracoabdominal organs while they are still in the donor’s body. This reduces the warm ischemic damage and allows organs to recover somewhat before being removed. The technique has expanded the pool of usable organs from circulatory-death donors, including making DCD heart transplantation feasible.
Adoption has been rapid but uneven. A survey of organ procurement organizations in the United States found that 89% had experience with NRP, but the median case volume was only 8 cases per organization. More concerning, nearly half of the organizations performing NRP were doing so without a formal policy or even a policy pending approval. The ethical dimensions are real: NRP involves restarting blood circulation in a person who has been declared dead based on the irreversible cessation of circulation, which some ethicists argue creates a tension with the declaration of death itself. These concerns have not stopped the spread of the technique, but they have prompted calls for formal regulation and standardized protocols.
How Legal Definitions of Death Shape the Timeline
The entire framework for organ donation depends on how and when death is declared, and this varies across jurisdictions in ways that directly affect how much time organs spend without blood flow. In brain death, the declaration happens while the heart is still beating, so organ recovery can proceed with minimal ischemia. In circulatory death, the clock is ticking from the moment circulation stops.
The variation in no-touch periods across countries reflects deeper disagreements about what constitutes irreversible cessation of cardiac function. A review of European DCD protocols documented large differences in legislation, the categories of donors accepted, and the way death is determined. Some countries require electrocardiographic silence for their entire observation period; others require only the absence of a pulse or arterial pressure. The practical consequence is that the same donor, dying in the same way, could have a different no-touch period depending on the country, resulting in different amounts of warm ischemic damage to the organs and different chances of successful transplantation.
Italy’s historically long 20-minute observation period, for example, made DCD programs more challenging to establish than in countries with 5-minute windows. Programs there have had to develop strategies to minimize warm ischemic damage despite the longer mandated wait, including preconditioning protocols and rapid deployment of preservation teams.